Back
Atour Lifestyle Holdings Vs. Novo Nordisk AS Industry Stock Comparison
Buy
66
ATAT
Atour Lifestyle Holdings
Last Price:
$28.00
Seasonality Move:
29.51%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Buy
66
Atour Lifestyle Holdings (ATAT)
is a Buy
Is Atour Lifestyle Holdings a Buy, Sell or Hold?
-
The current Atour Lifestyle Holdings [ATAT] share price is $27.99. The Score for ATAT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
ATAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATAT Stock Price Chart
What is Atour Lifestyle Holdings's stock price today?
-
The Atour Lifestyle Holdings share price today is $27.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
ATAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 56.61 | Buy |
| Chaikin Money Flow: | 532459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.38 - 27.72) | Buy |
| Bollinger Bands (100): | (19.26 - 27.76) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.5 | Sell |
| Relative Strength Index (14 RSI): | 19.69 | Sell |
| Chaikin Money Flow: | 20899665 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.63 - 110.99) | Sell |
| Bollinger Bands (100): | (107.27 - 131.41) | Sell |
ATAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.57 | Buy |
| 20-day SMA: | 26.7 | Buy |
| 50-day SMA: | 26.63 | Buy |
| 200-day SMA: | 20.84 | Buy |
| 8-day EMA: | 27.51 | Buy |
| 20-day EMA: | 27.05 | Buy |
| 50-day EMA: | 26.1 | Buy |
| 200-day EMA: | 22.22 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104.71 | Sell |
| 20-day SMA: | 106.65 | Sell |
| 50-day SMA: | 109.28 | Sell |
| 200-day SMA: | 126.25 | Sell |
| 8-day EMA: | 102.07 | Sell |
| 20-day EMA: | 105.53 | Sell |
| 50-day EMA: | 110.02 | Sell |
| 200-day EMA: | 118.09 | Sell |
Atour Lifestyle Holdings Earnings Growth & ATAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.29 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
Atour Lifestyle Holdings Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||